Trial · NCT00934791
Polycystic Liver Disease in Kidney Transplant
NCT00934791, Not applicable, Terminated, Mayo Clinic; results first posted 2013-03-08
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Polycystic Liver Disease in Kidney Transplant. Trials, record NCT00934791. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00934791
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Polycystic Liver Disease in Kidney Transplant
- NCT number
- NCT00934791
- Status
- Terminated
- Phases
- Not applicable
- Enrollment
- 2 participants, actual
- Lead sponsor
- Mayo Clinic
- Conditions
- Polycystic Liver Disease
- Interventions
- Tacrolimus, Sirolimus, Mycophenolate Mofetil, Prednisone
- First posted
- 2009-07-08
- Last updated
- 2013-03-08
- Results first posted
- 2013-03-08
- Limitations and caveats
- This study was terminated due to inadequate enrollment, no data was collected on the participant.
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Liver Volume at 2 Years After Kidney Transplantation | 2 years | Liver volume at 2 years will be compared between the sirolimus and control (tacrolimus) groups using analysis of covariance (ANCOVA). |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Liver Volume at 2 Years After Kidney Transplantation | 2 years | This study was terminated due to inadequate enrollment, no data was collected on the participant. |
Source ClinicalTrials.gov
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Control Group | 1 | |
| Overall Study | STARTED | Sirolimus Group | 0 | |
| Overall Study | COMPLETED | Control Group | 0 | |
| Overall Study | COMPLETED | Sirolimus Group | 0 | |
| Overall Study | NOT COMPLETED | Control Group | 1 | |
| Overall Study | NOT COMPLETED | Sirolimus Group | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Control Group | ||
| Total, all-cause mortality | Sirolimus Group | ||
| Total, other adverse events | Control Group | 0 | 1 |
| Total, other adverse events | Sirolimus Group | 0 | 0 |
| Total, serious adverse events | Control Group | 0 | 1 |
| Total, serious adverse events | Sirolimus Group | 0 | 0 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00934791
GET https://conductscience.org/api/trials/v1/NCT00934791/registered